Wockhardt informs about press release

16 Aug 2022 Evaluate

Wockhardt has informed that it enclosed the Press Release titled ‘Wockhardt announces successful initiation of Global Phase 3 Clinical Study of its novel antibiotic WCK 5222’.

The above information is a part of company’s filings submitted to BSE.

Wockhardt Share Price

1363.15 12.80 (0.95%)
22-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1634.40
Dr. Reddys Lab 1217.15
Cipla 1371.55
Zydus Lifesciences 884.85
Lupin 2165.05
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×